Company / Shareholders' Equity
KESTRA MEDICAL TECHNOLOGIES, LTD. Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$205.4M
FY2025
5-year range
-$209.4M / $205.4M
FY2023-FY2025
Trend
+198.1%
vs FY2024
Sector context
#136 of 161
Health Care
What the data says
KESTRA MEDICAL TECHNOLOGIES, LTD.'s shareholders' equity of $205M is lower than 84% of companies in the Health Care sector (FY2025). Improved from -$118M to $205M over the past 2 years.
Based on SEC 10-K filings.
$205M in FY2025.
Improved from -$118M to $205M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 161This company $205.4M Sector average $5.1B
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity increased 198.1% year-over-year.
- Ranks #136 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.4M | +198.1% |
| FY2024 | -$209.4M | -78.1% |
| FY2023 | -$117.6M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026